News & Deep Analysis
CELG-RI

Bristol-Myers Squibb Note Offering Completed (CELG-RI)

Published: November 10, 2025
BRISTOL MYERS SQUIBB CO

Direct News

  • Date: 2025-11-10
  • Issuer: Bristol-Myers Squibb (offering completed via subsidiary ticker CELG-RI)
  • Transaction: Multi-series note offering completed
  • Maturities: Series maturing between 2030 and 2055

Historical Context

Relevant recent events leading up to this offering: - 2025-11-03: Bristol-Myers Squibb initiated $7 billion in cash tender offers to repurchase notes. - 2025-10-30: The company announced the acquisition of Orbital Therapeutics. - 2025-10-30: Q3 2025 financial results were released, showing revenue growth and updated guidance. This note offering, completed on 2025-11-10 via the CELG-RI subsidiary, follows the tender offer initiation earlier in November and the October announcements on acquisition and quarterly results. These prior actions provide the immediate context for investors reviewing the company’s recent financing and capital allocation activity.

Deal summary and structural note

On 2025-11-10 Bristol-Myers Squibb completed a multi-series note offering executed through its subsidiary identified by ticker CELG-RI. The transaction consists of multiple note series with stated maturities spanning from 2030 through 2055. The use of a subsidiary as the issuing vehicle and the range of maturities indicate a multi‑layered debt issuance that will add long‑dated obligations to the company's liability schedule. Observers tracking the company’s capital markets activity will place this closing alongside other recent balance-sheet actions to assess net changes in the company’s debt profile.

Investor FAQ

The most effective approach is to maintain a factual perspective. Keep a close watch on further developments at BRISTOL MYERS SQUIBB CO as they unfold. Use primary source data to validate your investment thesis rather than relying on delayed secondary reports.

You can set up an automated tracker on Portrak. Our system monitors official SEC filings in real-time, delivering the most critical insights to your phone or inbox seconds after publication—frequently before the information reaches major financial news platforms.

We believe quality intelligence should be accessible. Our business model is supported by professional investors with large, complex portfolios who utilize Portrak Pro. These users pay to automate the monitoring of extensive watchlists, saving hundreds of hours in research time, which allows us to keep the standard service free for individual investors tracking their core positions.

Setting up your automated intelligence pipeline is a simple 3-step process:

1

Create Your Free Account

Sign up or log in to access your personal dashboard.

2

Select Your Focus

Use the search bar to find companies like BRISTOL MYERS SQUIBB CO. Choose between monitoring specific events or receiving general market-moving intelligence. Our AI automatically determines what’s critical based on real-time market data and the company’s current profile.

3

Receive Real-Time Intelligence

Once activated, all official filings are analyzed instantly. Insights are delivered directly to your email or as a push notification if you use the Portrak mobile app.

Also available as a mobile app for iOS & Android—search for "Portrak"

More Strategic Insights